EASY BIO, Inc. Q3 operating profit KRW 11.5 billion, up 2.6% from a year earlier
AI summary · Not investment advice
EasyBio sold KRW 140.0 billion worth in Q3 and made KRW 11.5 billion from its main business, up 2.6% from a year earlier and down 23.4% from the prior quarter.
Operating profit · 3 months
KRW 11.5 billion
Key facts
- Revenue (3 months)
- KRW 140.0 billion
- Net income (3 months)
- KRW 1.2 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 116.9 billion
- Revenue (year to date)
- KRW 418.9 billion
- Operating profit (prior-year 3 months)
- KRW 11.2 billion
- Operating profit (year to date)
- KRW 39.8 billion
- Net income (prior-year 3 months)
- KRW 8.6 billion
- Net income (year to date)
- KRW 23.8 billion
Commentary
AI commentary · Not investment advice
What happened
EG Bio reported its consolidated results for the 3rd quarter of 2026 in its quarterly report. Sales for the latest 3 months were KRW 140.03 billion. In the same 3 months a year earlier, sales were KRW 116.90 billion. Cumulative sales this year are KRW 418.86 billion.
In the company's terms
Sales rose 19.8% from a year earlier. They fell 5.5% from the previous quarter.
What changes for shareholders
Operating profit (profit from the core business) for the latest 3 months was KRW 11.53 billion. That is 2.6% above the KRW 11.25 billion of a year earlier. It is 23.4% below the previous quarter. Cumulative operating profit this year is KRW 39.81 billion.
Net income (the final profit after taxes and other costs) for the latest 3 months was KRW 1.24 billion. That is 85.7% below the KRW 8.63 billion of a year earlier. It is 88.6% below the previous quarter. Cumulative net income this year is KRW 23.76 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
E